Dexcom Inc Stock Price on December 26, 2024
| DXCM Stock | USD 80.56 0.32 0.40% |
Below is the normalized historical share price chart for DexCom Inc extending back to April 14, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of DexCom stands at 80.56, as last reported on the 26th of December, with the highest price reaching 80.83 and the lowest price hitting 78.59 during the day.
If you're considering investing in DexCom Stock, it is important to understand the factors that can impact its price. DexCom appears to be very steady, given 3 months investment horizon. DexCom Inc secures Sharpe Ratio (or Efficiency) of 0.15, which denotes the company had a 0.15% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for DexCom Inc, which you can use to evaluate the volatility of the firm. Please utilize DexCom's Mean Deviation of 1.55, downside deviation of 1.66, and Coefficient Of Variation of 895.37 to check if our risk estimates are consistent with your expectations.
DexCom Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of April 2005 | 200 Day MA 96.9768 | 50 Day MA 74.7842 | Beta 1.173 |
DexCom |
Sharpe Ratio = 0.1451
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | DXCM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.09 actual daily | 18 82% of assets are more volatile |
Expected Return
| 0.3 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average DexCom is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DexCom by adding it to a well-diversified portfolio.
Price Book 15.837 | Enterprise Value Ebitda 32.2365 | Price Sales 7.9265 | Shares Float 387.5 M | Wall Street Target Price 96.2633 |
Related Headline
Cigna Corp Headline on 26th of December 2024
Filed transaction by Cigna Corp Officer Chief Accounting Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
DexCom Valuation on December 26, 2024
It is possible to determine the worth of DexCom on a given historical date. On December 26, 2024 DexCom was worth 80.24 at the beginning of the trading date compared to the closed value of 80.56. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of DexCom stock. Still, in general, we apply an absolute valuation method to find DexCom's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of DexCom where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against DexCom's related companies.
| Open | High | Low | Close | Volume | |
| 79.56 | 80.83 | 78.59 | 80.24 | 1,152,987 | |
12/26/2024 | 80.24 | 80.83 | 78.59 | 80.56 | 0.00 |
| 80.24 | 80.83 | 78.59 | 80.56 | 0.00 |
| Backtest DexCom | | | DexCom History | | | DexCom Valuation | Previous | Next |
DexCom Trading Date Momentum on December 26, 2024
| On December 26 2024 DexCom Inc was traded for 80.56 at the closing time. The top price for the day was 80.83 and the lowest listed price was 78.59 . There was no trading activity during the period 0.0. Lack of trading volume on December 26, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.40% . |
DexCom Inc Fundamentals Correlations and Trends
By evaluating DexCom's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among DexCom's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. DexCom financial account trend analysis is a perfect complement when working with valuation or volatility modules.About DexCom Stock history
DexCom investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for DexCom is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in DexCom Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing DexCom stock prices may prove useful in developing a viable investing in DexCom
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California. Dexcom operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 6300 people.
DexCom Quarterly Net Working Capital |
|
DexCom Stock Technical Analysis
DexCom technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
DexCom Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
DexCom Inc cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
DexCom December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how DexCom stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading DexCom shares will generate the highest return on investment. By undertsting and applying DexCom stock market strength indicators, traders can identify DexCom Inc entry and exit signals to maximize returns
DexCom Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for DexCom's price direction in advance. Along with the technical and fundamental analysis of DexCom Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of DexCom to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0955 | |||
| Jensen Alpha | 0.2052 | |||
| Total Risk Alpha | 0.1336 | |||
| Sortino Ratio | 0.1149 | |||
| Treynor Ratio | 0.3933 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.157 | Earnings Share 1.65 | Revenue Per Share 10.089 | Quarterly Revenue Growth 0.02 | Return On Assets 0.0606 |
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.